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Summary
Background.— Since the prospective payment system, health institutions have only speciﬁc pay-
ments for the emergency care in the emergency room. The direct urgent admissions in coronary
care units for acute coronary syndrome (ACS) do not collect this complementary refund. For
the patient’s stay, hospital is remunerated with ﬁxed national prices which are similar even in
case of emergent or planed coronary revascularization when realized.Cost analysis; Aims.— To analyze and compare the ﬁnancial impact between emergent and planed coronary
S.Emergency stenting in the setting of ACPatients and methods.— This retrospective study was based on patients suffering from ACS who
experienced emergent coronary stenting during the year 2005. On 154 patients, 127 were age-,
sex- and diagnosis-related group (called ‘‘groupe homogène de malades’’ in the French Health
Care system)-matched with 127 suffering from same ACS but with planed ‘‘ad hoc’’ coronary
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stenting. The overall charges (medical and paramedical team, pharmacy, biology, implantable
coronary devices, radiology) were compared between the two groups. Results Mean stay
duration was 6.7 days and did not differ between the two groups. Mean ﬁnancial retribu-
tions were signiﬁcantly higher in the emergent group (7338D [6831—7846] IC95 vs 6509D
[5994—7023]; p = 0,02) but with a much more raised consumption (6810D [6283—7336] vs 5223D
[4632—5814]; p = 0,001). This overcost was due especially to drugs and biological expenses. The
hospitalization payments did not cover the overall expenses for 25% of the patients’ stays
(N = 64) among whom 39 have had emergent coronary stenting (30.7%, p = 0.04). Among the
different GHM, the most important difference was observed in non-STEMI without complication
with a negative receipts/costs ratio for 37.8% of the stay with coronary stenting in emergency.
Conclusion.— The application of the recent guidelines for coronary revascularization in the
management of ACS represents a ﬁnancial venture for hospital institutions. The engaged charges
for emergent coronary stenting are covered with difﬁculties contrary to planed revasculariza-
tion.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Introduction.— Depuis la mise en place de la tariﬁcation à l’activité (T2A), les établissements
de santé publics disposent de ﬁnancement spéciﬁque pour la prise en charge des urgences effec-
tuées par les services d’urgences. En revanche, les entrées directes en urgence dans les services
de soins, ne donnent pas lieu à un ﬁnancement complémentaire spéciﬁque. Cela s’applique à
la prise en charge des syndromes coronariens aigus (SCA) admis en unité de soins intensifs de
cardiologie (USIC) et pris en charge immédiatement par cathétérisme interventionnel. Pour ces
séjours, l’établissement ne perc¸oit qu’un tarif déﬁnit au niveau national équivalent en urgence
comme en programmé. À partir des données d’activité issues du PMSI et du service de car-
diologie, nous avons étudié l’impact ﬁnancier de la prise en charge en urgence des SCA avec
pose d’endoprothèse coronarienne par rapport à une prise en charge équivalente mais de fac¸on
programmée.
Méthode.— Cette étude rétrospective a porté sur les poses en urgence de stents coronaires
de l’année 2005 dans notre service de cardiologie. Sur 154 patients pris en charge pour SCA
avec sus-décalage ST persistant, ou sans sus-décalage à haut risque pris en urgence en salle de
cathétérisme, 127 ont pu être appariés sur l’âge, le sexe et le groupe homogène de malades
(GHM) avec 127 patients ayant bénéﬁcié d’une pose de stent à l’issue d’une coronarographie
programmée. Pour ces 254 séjours, l’ensemble des charges (personnels, pharmacie, biolo-
gie, radiologie, DMI) et des recettes ont été rattachées aux séjours correspondants. L’analyse
réalisée selon le type de prise en charge a porté sur les recettes et les charges constatées.
Résultats.— La durée moyenne des séjours est de 6,7 jours [5,9—7,4] IC95 et ne diffère pas
selon le type de prise en charge. Il existe une valorisation moyenne par séjour signiﬁcativement
supérieure pour les prises en charge urgentes (7338D [6831—7846] IC95 vs 6509D [5994—7023] ;
p = 0,02) mais avec un écart plus marqué sur les dépenses (6810D [6283—7336] vs 5223D
[4632—5814] ; p = 0,001). Ce surcoût est lié aux dépenses médicamenteuses (anti-GPIIb/IIIa) et
aux examens biologiques. Les recettes d’hospitalisation ne couvrent pas les dépenses engagées
pour 25 % des séjours (n = 64) parmi lesquels 39 ont un type de prise en charge en urgence
(30,7 %) (p = 0,04). Parmi les différents GHM, la différence la plus importante entre les deux
types de prises en charge est observée dans le groupe 05K06V (endoprothèses vasculaires sans
infarctus sans comorbidité), avec un écart recettes/dépenses négatif pour 37,8 % des séjours
avec prise en charge en urgence (n = 14) (p = 0,03).
Conclusion.— L’application des récentes recommandations sur la prise en charge des SCA
avec pose d’endoprothèse en urgence représente un investissement pour les hôpitaux dont
la valorisation ﬁnancière couvre difﬁcilement les dépenses engagées contrairement aux poses
programmées.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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Introduction
Since the introduction of activity-based funding in 2004
(T2A1), public health establishments receive speciﬁc fund-
ing for medical or surgical emergencies carried out by the
emergency services [1]. This funding is broken down into a
ﬁnancial budget that is connected to the volume of activ-
ity undertaken, and an annual set budget. The funding
connected to the activity undertaken incorporates national
prices that are applied to each hospital short-term stay in
the emergency department of the hospital catchment area
as well as a ﬂat rate of 25D (ATU) granted for each time
a patient is admitted to the emergency department, to
which are added rates for procedures carried out that fall
under the French National Health Insurance Scheme (CCAM)
and under the General Professional Procedure Nomencla-
ture (NGAP). The ﬂat-rate ﬁnancing includes the annual
emergency ﬂat rate (FAU) which is to cover the ﬁxed costs
of the emergency department, especially personnel and
facilities [2,3]. However, direct emergency admissions to
the nonemergency medical department do not give rise to
speciﬁc additional funds. This applies mainly to the treat-
ment of acute coronary syndromes (ACS) admitted in an
emergency to the cardiac intensive care unit (UCIS) and
immediate treatment for surgical catheterisation. For these
admissions, the establishment receives a rate based on the
diagnosis-related group (DRG), which is laid down at national
level and to which are added daily intensive care and reani-
mation supplements. So, the rate allocated to each hospital
stay does not differ depending on whether the patient’s
treatment is performed as an emergency or whether it
is planned. The organisational consequences, however, of
emergency treatment by the medical care services are not
negligible. Nonscheduled medical procedures as a causal
factor of cost discrepancies were mentioned in the IGAS
report [4]. Based on activity data from the IT Medical Care
Provision Programme (PMSI) and the cardiology department,
the aim of this paper is to study the ﬁnancial impact of non-
scheduled treatment of ACS with the insertion of a coronary
stent compared with scheduled treatment, and to exam-
ine variables to explain this, if supplementary costs are
incurred, and the share allocated to each of them. After
this analysis, a comparison was carried out between the
observed expenses and the income received per hospital
stay.
Methodology
Deﬁnitions of the scope of the study and
identiﬁcation of the population studied
This is a retrospective study carried out using activity data
for 2005 in our cardiology department. The study deals
with hospital stays for the treatment of ACS requiring a
coronary stent to be inserted. The stays that have been
taken into account are those between 01 January 2005 and
1 The resources of the hospital are determined by the amount of
treatment administered, rather than being allocated a set budget,
also known as case-mix funding.
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1 December 2005. These stays have been differentiated
ccording to the type of patient care, making a distinction
etween emergency and scheduled treatment. This concern
s particularly felt in the cardiology department due to its
egional catchment area.
eﬁnition of an emergency
he deﬁnition of emergency treatment with catheterization
nd the insertion of an endoprosthesis applies to patients
aving suffered an ACS requiring the patient be transferred
o coronarography in the UCIS upon admission. After a
linical and paraclinical assessment, the senior cardiolo-
ist on duty conﬁrms the need to transfer the patient to
oronarography immediately in order to ensure coronary
evascularisation as quickly as possible. The type of patient
hat ﬁts this criterion is patients suffering from an ACS with
ersistent ST segment elevation, possibly with haemody-
amic complications (cardiogenic shock), or suffering from
recurring ACS without ST segment elevation, or patient
ho do not respond to normal medical treatment. Mechan-
cal complications of the myocardial infarction that also
equire emergency coronarography care are excluded from
his study, as are the cases leading to an indication for
urgical intervention. Only patients that underwent ad hoc
evascularisation with coronary stenting are covered in this
aper.
eﬁnition of DRG and clinical correspondence
or each stay with emergency treatment entailing the inser-
ion of a coronary stent, matching was carried out during
stay where a coronary stent was inserted followed by
scheduled coronary exploration on the same time. The
atching was based on patient variables (age, gender) and
n the stay (case-mix group [CMG]) resulting from data
ompiled on the activity of the stay. The typing of these
tays varies according to the main diagnosis recorded in the
edical unit summary, any complications and morbidities
ssociated with the main treatment, and medical treatment
arried out, in this case revascularisation using a coronary
tent. This information results in the patient being allo-
ated to one of four DRG in accordance with version 10.10 of
he typing algorithm: PMSI 05K05V ‘‘vascular endoprosthe-
es and myocardial infarction (MI) without complications and
ssociated morbidities (CAM)’’ and 05K05W ‘‘vascular endo-
rostheses and MI with death and/or complications and/or
ssociated morbidities’’. These two groups correspond in
ractice to primary angioplasty cases or a transfer to the
‘emergency’’ group. The ‘‘scheduled’’ patients in these
wo DRG correspond to patients with ACS with raised ST
egmentation hospitalised too late or transferred after suc-
essful thrombolysis in a nearby establishment. Coronary
ngioplasty with a stent is then carried out some time after
dmission. Both of the other two remaining groups, 05K06V
‘vascular endoprostheses without MI without CAM’’ and
5K06W ‘‘vascular endoprostheses without MI with CAM’’
orrespond to coronary endoprostheses proposed without
aised ST segmentation. Emergency corresponds to exam-
nation with stents carried out on patients ACS without
efractory raised ST segmentation or accompanied by seri-
us symptoms. The scheduled situations correspond to the
ame circumstances, but without raised ST segmentation,
4a
c
2
o
t
a
l
o
c
r
i
c
b
f
m
m
C
T
s
•
•
•
I
T
d
[
c
i
T
a
a
t
m
t
m
o
t
d
t
P
P
c
i
f
d
h
b
M
M
d
a
i
s
f
M
b
o
M
M
e
o
t
c
b
w
d
m
i
t
M
M
d
p
d
t
g
s
c
s
t
L
T
l
p
s
b
e
u
d
i
l
s
V
H12
nd that are not with high risk, such that a coronarography
an be planned a certain time after admission.
Each case-mix group has been attributed to a DRG since
004, and activity-based funding for medicine, surgery and
bstetrics (MSO) has been applied since then. The DRG is a
ariff that is calculated at national level and is common to
ll public health establishments; it is allocated to the estab-
ishment to look after this patient. The notion of emergency
r scheduled treatment does not change the amount allo-
ated for the treatment of each patient. The information
ecorded in the medical summary documents is systemat-
cally checked to ensure the quality of the matching. The
oding of the main diagnoses and associated diagnoses has
een reviewed for each ﬁle included based on information
ound in the medical ﬁle. No errors were found regarding the
ain diagnosis, associated diagnoses or the medical treat-
ent recorded in the ﬁles selected for this study.
ompiling the variables
he variables compiled for the analysis came from three
ources:
medical activity data from the PMSI for ‘‘patient’’ data
(gender, age, postcode of the patient’s place of residence)
and ‘‘stay’’ information (date admitted/discharged,
length of stay and time spent in each of the medical
units, date and type of treatment carried out/medication
prescribed, case-mix group and cost of the stay);
the database created by the cardiology department that
gives details for each patient treated with a stent, stating
whether the treatment was urgent or scheduled;
the medical ﬁles of the data on medical treatment per-
formed by the cardiology department (costly medical
treatment used [Reopro®] and medical implant devices
[MID]).
mputation of hospitalisation expenditure
he methodology used to break down hospitalisation expen-
iture is that laid down by the National Costs Study (ENC)
5]. Expenditure is divided up according to whether it is
harged directly or indirectly to the hospital stay. If the
nformation is known, the expenditure is allocated by stay.
his is direct expenditure. If the information is not avail-
ble to allocate the expenditure to a stay, the basis for cost
llocation for this expenditure is chosen in accordance with
he recommendations laid down in the analytical accounting
ethodology guide of the ENC study [5,6]. The expenditure
aken into account in this study is that of all the depart-
ents that took part in patient treatment. The expenditure
f the medical—technical cardiology platform appears in
he expenditure of the medical—technical platforms broken
own according to the cost allocation base referred to as
he relative cost index (ICR) used by the clinical services.
ersonnel and clinical services expenditure
ersonnel expenditure is divided into medical, paramedi-
al personnel and other personnel. The cost of personnel
s divided into medical units according to the allocation of
unds declared by the health executive and the head of
epartment. This expenditure identiﬁed by the medical unit
a
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as been broken down indirectly by stay. The cost allocation
ase of this expenditure is the day of hospitalisation.
edication and medical device expenditure
edication and medical device expenditure is allocated
irectly to the stay as soon as the information has been
scertained and is available, and more particularly for med-
cation and MID that may signiﬁcantly change the cost of the
tay. This is the case of abxicimab (Reopro®), used mainly
or urgent treatment of ACS, and coronary endoprostheses.
edication and medical device expenditure that has not
een possible to attribute directly to the stay is broken down
n a pro rata basis of expenditure already recorded.
edical logistics expenditure
edical logistics expenditure includes pharmaceutical
xpenditure (operating costs of the pharmacy, i.e. salary
f the personnel allocated to this department, amortisa-
ion and maintenance of equipment speciﬁc to this activity,
onsumables), sterilisation, medical IT department (DIM),
iomedical engineering as well as expenditure connected
ith vigilance (hemovigilance, pharmacovigilance, medical
evices vigilance). This expenditure is itemised for each
edical unit that incurs the expenditure. This expenditure
s then broken down on a pro rata basis per days of hospi-
alisation.
edical—technical services expenditure
edical—technical services are services that perform proce-
ures quoted in the form of a RCI (for surgery, exploratory
rocedures, anaesthesiology, radiology), of B and nonstan-
ard B nomenclature (BHN) for laboratories, and sections
he patient passed through (recovery room, incoming emer-
ency ward). The expenditure of the medical—technical
ervices is broken down on a pro rata basis per cost allo-
ation base, and then procedures performed by the clinical
ervices. All medical—technical procedures were allocated
o one of the stays in this study.
ogistics and general management expenditure
his expenditure includes in particular expenditure on
aundry, catering and administrative costs, admissions and
atient management, maintenance, moving patients on a
tretcher. The laundry and catering expenditure is allocated
y the medical unit according to the level of consumption of
ach one. Other expenditure is broken down by the medical
nit according to expenditure already recorded. This expen-
iture is then broken down for each stay on a pro rata basis
n terms of the number of days of hospitalisation. Estab-
ishment expenditure has not been broken down by hospital
tay.
aluation of stays
ospitalisation income linked to each stay is calculated in
ccordance with the tariffs and tariff regulations of 2006.
his income includes the stay tariff or DRG to which is
dded if relevant: the valuation of the supplementary days
ccounted for beyond the upper limit of the DRG, supple-
ents for reanimation and/or intensive care, renal dialysis
e co
T
t
0
a
o
w
T
a
w
w
1
d
E
T
i
c
e
m
t
a
t
i
b
s
a
a
7
A
b
r
5
t
e
t
i
e
(
i
c
(
i
o
c
t
h
a
t
1
c
w
d
1
1Financial impact of coronary stenting in emergency for acut
sessions, income from MID paid over the hospitalisation tar-
iff. The valuation ﬁgures are calculated at 100% of the
activity-based rate.
Data analysis
The medical data were recorded in Excel 2000®. The PMSI
activity data come from the software Orbis® (by Agfa). The
data were analysed using StatView® (SAS Institute, Berke-
ley, CA). The continuous variables (age, length of stay) are
expressed as an average, with a conﬁdence interval of 95%,
and a distribution median of the length of the stay. The nom-
inal variables (gender, entry method) are presented as gross
data and frequency of distribution. The nonmatched t-test
was used to analyse continuous variables. If the conditions
were not met to use the t-test, the U-Mann and Whitney
test was used to analyse the continuous variables. The 2
test was used to test for differences between category vari-
ables. The level of signiﬁcance (p) was set at 0.05. A value
of p under 0.05 was considered to be statistically signiﬁcant.
Results
During 2005, 154 patients were admitted to the emergency
department, with an ACS and who were ﬁtted with a coro-
nary stent, which comes to 5.7% of all patients (N = 2723)
treated in the cardiology department in 2005 and 3.3% of
stays (N = 4632) over this period. Eighty-seven (68.5%) of
the medical procedures were carried out outside of working
hours, of which 36 (28.3%) at the weekend and on national
holidays and 51 (40.2%) during the night. Scheduled treat-
ments represented 449 stays and patients in 2005, i.e. 16.5%
of patients and 9.7% of stays in 2005. Matching between
stays for emergency treatment and scheduled treatment
was performed for 127 of the 154 stays (82.5%) for the
three following variables: age, gender and case-mix group.
In total, the study is based on 254 stays for coronary treat-
ment requiring the insertion of a coronary stent.
Sociodemographic characteristics of the
patients (N=254)
Table 1 shows the sociodemographical characteristics of the
patients included. There is no statistically signiﬁcant differ-
ence between the emergency cases and patients whose stay
was scheduled for the matching variables (gender and age).
Characteristics of the stays (N=254)
The case-mix group was a stay-matching variable, so there
was no statistically signiﬁcant difference in the distribu-
tion of these case-mix groups between patients admitted as
an emergency and those admitted for scheduled treatment
(p > 0.05) (Table 1). The stays 05K05V (ACS with raised ST
segmentation) and 05K06V (ACS without raised ST segmen-
tation), without complications or associated comorbidity,
account for a majority of those in the study (N = 184; 72.4%).
The average length of the stay is 6.7 days [5.9; 7.4]CI95.
The median length of stay is 5 days. The average length
of stay does not vary signiﬁcantly according to whether
the patient is an emergency or scheduled case (p > 0.05).
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he average length of stay varies signiﬁcantly according
o case-mix group (p < 0.0001): 5.6 for the case-mix group
5K05V ‘‘vascular endoprostheses and MI without associ-
ted complications and morbidities’’ compared to 9.9 days
f hospitalisation on average for the same case-mix group
ith associated complications and/or morbidities (05K05W).
here is also a signiﬁcant difference with regard to the
verage length of stay for coronary endoprosthesis implants
ithout infarction: the average length of stay for patients
ithout complications (05K06V) is 5.0 days compared with
0.8 days if a complication or a comorbidity is declared
uring the stay (05K06W).
xpenditure and income for stays (N=254)
he total value observed for all stays included in the study
s 1,758,597D (Tables 2 and 3). Expenditure for these stays
omes to 1,528,216D , i.e. a difference between income and
xpenditure of 230,381D . For stays with scheduled treat-
ent, the total value comes to 826,621D ; hospital expendi-
ure comes to 663,331D , i.e. a difference between income
nd expenditure of 163,290D . For stays with emergency
reatment, the total value comes to 931,976D ; hospital-
sation expenditure comes to 864,884D , i.e. a difference
etween expenditure and income of 67,092D . There is a
tatistically signiﬁcant difference (p = 0.02) between the
verage value per stay observed for emergency treatment
nd scheduled treatment: respectively 7338.4D [6830.80;
846.00]CI95 compared to 6508.80D [5994.10; 7023.50]CI95.
verage expenditure incurred per stay differs signiﬁcantly
etween emergency and scheduled cases (p = 0.001) with
espectively 6810.10D [6283.60; 7336.70]CI95 compared to
223.10D [4631.80; 5814.40] CI95. Expenditure incurred by
he medical—technical services (laboratories, imaging, and
xploratory procedures) makes up the number one expendi-
ure item for stays. This expenditure accounts for 922,082D ,
.e. 60.3% of total expenditure. After that comes personnel
xpenditure (26.5%; 405,479D ) and medication expenditure
9.00%; 136,887D ). The extra costs of treating ACS cases to
nsert an emergency coronary stent can be seen for medi-
ation expenditure (p < 0.0001) and laboratory expenditure
p < 0.0001). Treatment with GP IIb/IIIa inhibitor type abx-
cimab are at the root of extra medication costs, coming
n average to a difference of 600D between emergency
ases of ACS and scheduled cases (p < 0.0001). Hospitalisa-
ion income does not cover the expenditure incurred to treat
ospitalised patients for 25.2% of stays (N = 64) of which 39
re emergency cases (30.7%) (p = 0.04).
If related to the length of hospitalisation, the
otal income represents on average 1432.90D [1330.80;
535.2]CI95 per day of hospitalisation for scheduled stays
ompared with 1,254.70D [1,160.20; 1,349.20]CI95 for stays
ith emergency treatment (p = 0.01). Total expenditure per
ay of hospitalisation is on average 1012.70D [962.10;
063.30]CI95 for scheduled stays and 1039.80D [986.60;
093.10]CI95 for emergency stays.
The difference between income and expenditure
ecorded is almost two and a half times higher for sched-
led stays compared to the difference recorded for stays
n emergency cases. This difference is statistically dif-
erent between the two stay groups (p = 0.003) with on
verage +1285.70D [1,000.7; 1,570.70]CI95 between the
414 D. Nidegger et al.
Table 1 Summary table of the characteristics of stays in 2005 for ischemic cardiopathy treated with coronary stent
(N = 254): distinction according to whether the treatment was an emergency (N = 127) or scheduled (N = 127).
Emergency
treatment (N = 127)
Scheduled
treatment (N = 127)
The whole
population (N = 254)
p
Gender
Female 21 (16.5) 21 (16.5) 42 (16.5) NS
Male 106 (83.5) 106 (83.5) 212 (83.5)
Age
Average
CI95
58.9 years 60.5 years 59.7 years NS
[56.7; 61.3]CI95 [58.3; 62.8]CI95 [58.1; 61.4]CI95
Min 30 34 30
Max 85 87 87
Case-mix group
05K05V 55 (43.3) 55 (43.3) 110 (43.3) NS
05K05W 23 (18.1) 23 (18.1) 46 (18.1)
05K06V 37 (29.1) 37 (29.1) 74 (29.1)
05K06W 12 (9.4) 12 (9.4) 24 (9.4)
Average length of stay
Average 7.3 days 6.1 days 6.7 days NS
CI95 [6.4; 8.2]CI95 [5.0; 7.2]CI95 [5.9; 7.4]CI95
Median 6 days 4 days 5 days
Minimum value observed 2 days 2 days 2 days
Maximum value observed 33 days 48 days 48 days
Average length of stay by case-mix group
05K05V (N = 55) 5.8 days 5.4 days 5.6 days NS
CI of the average at 95% [5.1; 6.5]CI95 [4.5; 6.4]CI95 [5.0; 6.2]CI95
6 days 4 days 5 days
Median 10.9 days 8.8 days 9.9 days NS
05K05W (N = 23) [7.5; 14.3]CI95 [6.3; 11.4]CI95 [7.7; 12.0]CI95
CI of the average at 95% 7 days 6 days 6.5 days
6.5 days 3.5 days 5.0 days < 0.001
Median [5.1; 7.8]CI95 [3.0; 4.0]CI95 [4.2; 5.8]CI95
05K06V (N = 37) 6 days 3 days 4 days
CI of the average at 95% 9.7 days 11.8 days 10.8 days NS
[5.9; 13.5]CI95 [3.6; 20.0]CI95 [6.3; 15.2]CI95
Median 7 days 4 days 6.5 days
05K06W (N = 12)
CI of the average at 95%
Median
The method of admission ‘‘Transfer’’ is deﬁned as a patient admitted from another legal body for hospitalisation. The discharge method
‘‘Transfer’’ is deﬁned as patient discharged to another legal body for hospitalisation. A ‘‘Move’’ is deﬁned as a patient discharged to
another medical unit within the same legal body. The method of admission ‘‘Move’’ is deﬁned as a patient admitted from another
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ncome and expenditure for scheduled stays compared with
528.30D [124.6; 931.90]CI95 on average for stays with
mergency treatment. The maximum negative difference
ecorded between income and expenditure for these stays
omes to −15,398D for emergency cases compared with
5370D for scheduled stays. The maximum positive dif-
erence recorded between the income and expenditure for
hese stays comes to +4240D for emergency stays com-
ared with +4302D for scheduled stays. The average of
hese differences between income and expenditure per
ay of hospitalisation is signiﬁcantly different between
he two populations (p < 0.0001), i.e. 420.30D [349.30;
w
i
+
c
iﬁcant.
91.30]CI95 per day for scheduled stays compared with
14.80D [147.20; 282.50]CI95 for emergency cases. Analy-
is by case-mix group reveals a signiﬁcant disparity with
egard to the difference between income and expenditure
etween scheduled stays and emergency stays. This differ-
nce appears to be signiﬁcant for case-mix group 05K06V
ACS without raised ST segmentation without complications)
ith on average +1138.40D [855.50; 1,421.30]CI95 between
ncome and expenditure for scheduled stays compared with
183.60D [−290.90; 658.I]CI95 on average for emergency
ases (p < 0.001). The gap between income and expenditure
s not signiﬁcantly different between the two groups for the
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Table 2 Summary table of the income resulting from stays in 2005 for ischaemic cardiopathy treated with coronary
stent (N = 254): distinction according to whether the treatment was an emergency (N = 127) or scheduled (N = 127).
Emergency
treatment (N = 127)
Scheduled
treatment (N = 127)
The whole
population (N = 254)
p
Diagnosis-related group (DRG) (N = 254)
Average (D ) 4203.3 4203.3 4203.3 NS
CI95 [4044.6; 4362.0]CI95 [4044.6; 4362.0]CI95 [4091.3; 4315.3]CI95
Minimum value observed (D ) 3642.6 3642.6 3642.6
Maximum value observed (D ) 5677.1 5677.1 5677.1
Upper peaks (N = 16)
Average (D ) 3171.4 5955.6 4041.5 0.15
CI95 [1472.2; 4870.6]CI95 [1971.2; 9940.0]CI95 [2288.5; 5794.5]CI95
Minimum value observed (D ) 418.4 1928.1 418.4
Maximum value observed (D ) 9640.7 13540.2 13540.2
Value of intensive care (N = 209)
Average (D ) 2131.6 2080.5 2111.5 0.76
CI95 [1953.4; 2309.8]CI95 [1770.8; 2390.2]CI95 [1949.2; 2273.9]CI95
Minimum value observed (D ) 417.1 417.1 417.1
Maximum value observed (D ) 9176.6 9593.8 9593.8
Value of dialysis sessions (N = 1)
Average 6630D 0D 6630D NS
CI95 — —
Minimum value observed (D ) 0 0 0
Maximum value observed (D ) 6630 0 6630
Total value of stays
Average (D ) 7338.4 6508.8 6923.6 0.02
CI95 [6830.8; 7846.0]CI95 [5994.1; 7023.5]CI95 [6559.3; 7287.9]CI95
Minimum value observed (D ) 4771.9 3937.6 3937.6
Maximum value observed (D ) 24110.4 29201.1 29201.1
Total value per case-mix group
05K05V (N = 110) (D ) 6288.5 5963.0 6125.8 0.05
CI of the average at 95% [5993.7; 6583.3]CI95 [5556.5; 6369.6]CI95 [5873.9; 6377.6]CI95
05K05W (N = 46) (D ) 10081.0 9081.9 9581.4 NS
CI of the average at 95% [8378.9; 11783.2]CI95 [8186.3; 9977.5]CI95 [8619.4; 10543.5]CI95
05K06V (N = 74) (D ) 6454.4 4843.2 5648.8 <0.0001
CI of the average at 95% [5864.8; 7044.0]CI95 [4553.6; 5132.8]CI95 [5273.9; 6023.7]CI95
05K06W (N = 24) (D ) 9619.2 9214.62 9416.9 0.02
CI of the average at 95% [7335.9; 11902.4]CI95 [5469.8; 12959.3]CI95 [7270.5; 11563.2]CI95
o
t
t
c
c
c
t
i
oNS: non signiﬁcant (value in euros for 2005).
case-mix group 05K06W (ACS without raised ST segmentation
with complications) (N = 24), while noting that on average
the differences recorded between income and expenditure
for this case-mix group are negative for emergency cases,
coming to −601.80D [−3630.40; 2426.80]CI95.
Discussion
The description of our population complies with the
recommendations of guidelines on this topic; the major-
ity of urgent cases were primary angioplasty procedures
for ACS with raised ST segmentation and ACS without
raised ST segmentation with comorbidities or complications
[6,7].
w
s
t
c
tThis study attempted to evaluate the ﬁnancial impact
f nonscheduled treatment in the cardiology department,
he highest number of cases in this discipline. We showed
hat there is an additional cost of 1600D for emergency
ases compared to that for scheduled cases. This additional
ost stems from expenditure on the following items: medi-
ation, mainly for GP IIb/IIIa inhibitor drugs, and laboratory
ests. Personnel expenditure does not appear to be signif-
cantly different between the two groups, but the value
bserved is close to the level of signiﬁcance. This study
ould have greater impact if there were a larger number of
tays included. The additional costs observed for scheduled
reatment in the expenditure item of MID depend on the
ondition of the patients. The more stable the condition,
he more coronary lesions can be treated through inserting
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Table 3 Summary table of the characteristics of stays in 2005 for ischemic cardiopathy treated with coronary stent (N = 254): distinction according to whether the
treatment was an emergency (N = 127) or scheduled (N = 127).
Emergency treatment (N = 127) Scheduled treatment (N = 127) The whole population (N = 254) p
Clinical dept personnel expenditure 1778.1D [1483.9; 2072.2]CI95 1414.7D [1169.5; 1659.8]CI95 1596.4D [1404.0; 1788.8]CI95 0.06
Medical salaries 299.4D [246.3; 352.5]CI95 238.8D [196.6; 281.0]CI95 269.1D [235.0; 303.1]CI95 0.08
IDE salaries + AS 1244.1D [1051.1; 1437.1]CI95 997.5D [824.6; 1170.3]CI95 1120.8D [990.6; 1250.9]CI95 0.06
Salaries of other professionals 234.6D [184.3;284.9]CI95 178.4D [147.5;209.3]CI95 206.5D [176.8;236.2]CI95 0.06
Medication expenditure
Total average expenditure 862.6D [757.6; 967.6]CI95 215.3D [154.9; 275.7]CI95 538.9D [466.5; 611.3]CI95 < 0.0001
Expenditure excl. Reopro® 161.7D [112.6; 210.9]CI95 115.7D [95.6; 135.8]CI95 138.7D [112.1; 165.4]CI95 0.09
DMI expenditure 525.8D [469.8; 581.9]CI95 710.7D [614.2; 807.2]CI95 618.2D [561.4; 675.1]CI95 0.001
Medical logistics expenditure 39.1D [30.3; 47.9]CI95 29.9D [24.6; 35.2]CI95 34.5D [29.4; 39.7]CI95 0.08
Medical-technical services expenditure 2066.4D [1877.9; 2254.9]CI95 1609.9D [1478.5; 1741.4]CI95 1838.2D [1820.1; 1956.3]CI95 0.0001
Laboratory 403.4D [340.1; 466.8]CI95 249.9D [204.6; 295.3]CI95 326.7D [286.7; 366.7]CI95 0.0001
Medical imaging 89.2D [62.4; 115.9]CI95 60.2D [49.7; 70.6]CI95 78.8D [62.9; 94.7]CI95 0.18
Functional exploratory procedures 1092.9D [1033.6; 1152.3]CI95 1041.8D [1001.6; 1082.1]CI95 1067.1D [1031.2; 1102.9]CI95 0.16
General logistical expenditure 1515.0D [1289.3; 1740.7]CI95 1226.7D [1013.4; 1440.1]CI95 1370.9D [1214.9; 1526.9]CI95 0.07
Laundry 44.4D [38.7; 50.0]CI95 37.2D [30.6; 43.7]CI95 40.8D [36.4; 45.1]CI95 0.10
Catering 228.3D [199.2; 257.5]CI95 191.3D [157.7; 224.9]CI95 209.8D [187.5; 232.1]CI95 0.10
Other general logistics 1242.3D [1047.3; 1437.4]CI95 998.3D [824.9; 1171.6]CI95 1120.3D [989.2; 1251.4]CI95 0.07
Total expenditure per stay
Average 6810.1D 5223.1D 6016.6D 0.001
CI of the average at 95% [6283.6; 7336.7]CI95 [4631.8; 5814.4]CI95 [5532.2; 6501.0]CI95
Minimum value (D ) 2253.2 2208.1 2208.1
Maximum value (D ) 36881.0 26479.7 36881.0
Total expenditure per case-mix group
05K05V (D ) (N = 110) 5567.7 4909.4 5238.6
CI of the average at 95% [5124.5; 6010.9]CI95 [4368.1; 5450.7]CI95 [4884.91; 5592.2]CI95 0.009
05K05W (D ) (N = 46) 8869.1 7107.1 7988.1
CI of the average at 95% [6594.9; 11143.2]CI95 [5596.6; 8617.7]CI95 [6613.9; 9362.2]CI95 NS
05K06V (D ) (N = 74) 6270.8 3704.8 4987.8
CI of the average at 95% [5484.7; 7056.9]CI95 [3285.5; 4124.0]CI95 [4456.4; 5519.2]CI95 < 0.0001
05K06W (D ) (N = 24) 10221.1 7731.1 8976.1
CI of the average at 95 % [5020.4; 15421.7]CI95 [3481.8; 11980.4]CI95 [5652.8; 12299.4]CI95 NS
[Numbers; (%)]; NS: non signiﬁcant (expenditure given in euros). IDE: state registered nurse; AS: orderly; MID: medical implant devices.
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eFinancial impact of coronary stenting in emergency for acut
several coronary stents during the same procedure. The dif-
ference observed between income and expenditure is on
the whole positive for both, but it is two and half times
higher for scheduled treatment. It is important to state
that income does not cover the expenditure incurred in a
third of nonscheduled cases. Applying the applications of
learned societies on emergency angioplasty for ACS, in par-
ticular outside of normal working hours, involves a ﬁnancial
investment from the hospitals, as the costs incurred are only
partially covered by the DRG funding and supplements. With
the current remuneration method, scheduled coronary stent
implants on the contrary bring in great ﬁnancial beneﬁts,
particularly in the group of ACS without raised ST segmen-
tation without complications.
To this must be added, the organisational and ﬁnan-
cial impact of cancelling scheduled procedures. Emergency
treatment of some patients, apart from the additional costs
caused by this treatment, causes organisational difﬁculties
for the clinical services that are forced to cancel procedures
on patients that had already been planned. These cancelled
procedures lengthen scheduled stays and indirectly bring
about an increase in the cost of the stay. The ﬁnancial
impact of these cancellations has not been evaluated in our
study.
The quality of the medical data and the quality and
extent to which the income and expenditure was cor-
rectly allocated to the patient’s stay are key elements
in analysing each case. The methodology of this study is
centred on the quality of the data retrieval. The case-
mix group is one of the decisive variables in matching
stays. The quality of this information is essential in order
to ensure the quality of the analysis of the income and
expenditure by stay. The encoded medical data (diag-
nostics and CCAM procedures) were checked for all 254
stays by referring to the medical ﬁle and hospitalisation
report before matching up the stays. All hospitalisation
incomes were allocated to the stay concerned. Stay expen-
diture incurred was broken down into the main expenditure
items of medication, MID, and medical—technical pro-
cedures performed. In total, 50% of expenditure were
directly allocated to stays, including 100% of expenditure
on medical—technical procedures carried out. Of the med-
ical costs, only expenditure for nonimplantable medical
devices (and therefore not reimbursed over and above the
DRG) were not allocated directly to stays. The consumption
of medical devices is nonetheless higher for treatment of
emergency ACS cases (angioplasty balloon, thromboaspira-
tion catheter). This can reduce the actual cost for medical
devices of emergency admissions and reduce the actual
expenditure difference between scheduled and emergency
stays.
Few studies have been carried out on the ﬁnancial impact
of nonscheduled patient treatment [4,8,9]. A study con-
ducted on complete hospitalisation data in 2003 and sent
as part of the ENC by the University Hospitals of Strasbourg
showed that stays identiﬁed as nonscheduled entailed on
average an additional cost of 63% compared with scheduled
hospital stays [4]. Nonscheduled stays in the serious car-
diovascular events category appear to be less costly than
scheduled stays. However, the information on whether the
stay was scheduled or an emergency was not routinely avail-
able and was encoded later for all stays, which is one of
3
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he limits of the study. In our study, nonscheduled hospital-
sation for treatment of an ACS represented an additional
verage cost of 30.4% compared to scheduled hospitalisa-
ion. An Australian study [9] demonstrated that there was
signiﬁcant difference between the costs of emergency
nd scheduled admissions for surgery on an aneurism of
he abdominal aorta. An American study [10] showed for
ine surgical DRG, that emergency admissions usually entail
igher hospitalisation costs.
Medical economic studies carried out in cardiology
ere geared towards ‘‘cost-beneﬁt’’ analyses or ‘‘cost-
ffectiveness’’ of using new molecules or new invasive
echniques [11]. A French study assessed the cost of hospital
reatment of cardiovascular events using data from the PMSI
12]. The cost observed for coronary angioplasty using stent
as less than in our study, ranging from 5750D in the private
ector to 5178D in the public sector. Two other studies anal-
sed the cost of treating acute myocardial infarction using
he English-speaking equivalent—–APR-DRG—–of the French
MSI classiﬁcation [13,14]. For one of these studies [13],
he average cost of treating the infarction was between
261D ± 2768D and 7527D ± 4614D . The standard devia-
ions recorded reveal a high level of variability in costs per
tay. The second study [12] showed an increase in the cost of
esources used depending on the severity of the APR-DRG,
hich was also shown in our study. Nonetheless, the com-
arison with the data from our study remains limited since
he APR-DRG classiﬁcation algorithm cannot be strictly com-
ared with the algorithm applied in the French PMSI model.
he results of the ENC for the 2005 data showed average
osts by case-mix group similar to those recorded in our
tudy. The average gross cost without removing extreme val-
es observed on the 2005 ENC is 6350.70D for the 05K05V
ase-mix group, 9303.30D for the 05K05W case-mix group,
005.40D for the 05K06V case-mix group and 7840.30D days
or the 05K06W case-mix group. Only the cost recorded for
he 05K05V case-mix group is signiﬁcantly higher than the
ne recorded in our study.
imitations of the study
he ﬁnancial evaluation obtained for each stay and the
ost incurred for the treatment of an ACS vary according
o the type of procedure (medical treatment alone or car-
iac surgery) and the seriousness of the condition of the
atient requiring in some situations for the patient to be
ransferred to a reanimation or surgical unit. The study of
he additional cost of nonscheduled treatment requires cer-
ain factors to be excluded such as variability of costs and
ncome, in order to compare the stays according to the
‘scheduled/nonscheduled’’ variable alone. This led us to
pt for treatment of ACS requiring coronary stenting, as this
ctivity is carried out in coronarography at the same time for
oth scheduled and emergency cases. Due to this method-
logical choice, the results observed in our study cannot be
xtrapolated to include all emergency ACS cases, because
0% of ACS cases lead to medical procedures alone with-
ut coronary revascularisation. Finally, we did not assess
he ﬁnancial impact of the initial seriousness of the clini-
al conditions of the patients, estimated using a risk score
pon admission.
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onclusion
he description of our population complies with the rec-
mmendations of good practice; the majority of urgent
rocedures were primary angioplasties of ACS with raised
T segmentation and ACS without raised ST segmentation
ith comorbidities or complications. However, the ﬁnan-
ial value proposed for both of these DRG groups shows
hat it brings about the lowest level of positive differ-
nces between income and expenditure and the highest
egative differences. The application of the recommenda-
ions of learned societies on emergency procedures using
ngioplasty with stent for ACS, especially outside of normal
orking hours, involves a ﬁnancial investment by the hos-
itals, as the costs are only partially covered by income
rom the DRG or the USIC. With the current method of
emuneration, scheduled coronary stent implants provide
n the contrary the highest ﬁnancial beneﬁts, especially
n the ACS without raised ST segmentation group without
omplication. Continuing with this method of remuneration
T2A) could in the long term have a harmful impact on the
nancial capacities of our hospitals to treat cases of ACS
n accordance with guidelines. In order to achieve the best
ompromise between the health of our patients who have
uffered from an ACS and the ﬁnancial health of our hos-
itals, it is necessary to allocate speciﬁc additional funds
o hospitals offering speciﬁc emergency treatment, and the
edical profession must be able to respect the indications
or catheterization that may be carried out as a scheduled
rocedure.
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